Pfizer Proposes $75M Fund To Settle Shareholder Suits

Pfizer Inc. has offered a $75 million legal fee fund, along with promises to beef up its compliance program, aiming to end shareholder derivative suits against the top brass at the...

Already a subscriber? Click here to view full article